SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001144204-16-085821
Filing Date
2016-03-03
Accepted
2016-03-03 16:50:39
Documents
72
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K v432316_10k.htm 10-K 1096758
2 EXHIBIT 21.01 v432316_ex21-01.htm EX-21.01 3574
3 EXHIBIT 23.01 v432316_ex23-01.htm EX-23.01 2799
4 EXHIBIT 31.01 v432316_ex31-01.htm EX-31.01 11345
5 EXHIBIT 31.02 v432316_ex31-02.htm EX-31.02 11358
6 EXHIBIT 32.01 v432316_ex32-01.htm EX-32.01 5701
13 GRAPHIC tpg42.jpg GRAPHIC 42934
  Complete submission text file 0001144204-16-085821.txt   5397424

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT tnxp-20151231.xml EX-101.INS 1012243
8 XBRL TAXONOMY EXTENSION SCHEMA tnxp-20151231.xsd EX-101.SCH 51198
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE tnxp-20151231_cal.xml EX-101.CAL 46218
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tnxp-20151231_def.xml EX-101.DEF 320528
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE tnxp-20151231_lab.xml EX-101.LAB 378984
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tnxp-20151231_pre.xml EX-101.PRE 362821
Mailing Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 306 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36019 | Film No.: 161481956
SIC: 2834 Pharmaceutical Preparations